Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Prostatic Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Hand-Foot Syndrome 1Colorectal Neoplasms 1Chemotherapy-Related Cognitive Impairment 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cognitive Training 2Vitamin D 1Tobacco Use Cessation Devices 1Synbiotics 1Sodium Chloride 1Saline Solution 1Prebiotics 1Neuroprotective Agents 1Mesna 1Magnetic Resonance Spectroscopy 1High-Intensity Interval Training 1Functional Status 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chemotherapy-Related Cognitive Impairment × Tobacco Use Cessation Devices × Breast × Clear all
NCT02312934 2020-01-21

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Vanderbilt University Medical Center

Phase 2 Completed
22 enrolled 14 charts
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡